Paratek's Phase III trial of omadacycline shows positive outcome in CABP treatment
US-based biopharmaceutical firm Paratek Pharmaceuticals has reported positive top-line results from its Phase III clinical trial of omadacycline to treat community-acquired bacterial pneumonia (CABP) patients. (Source: Drug Development Technology)
Source: Drug Development Technology - April 3, 2017 Category: Pharmaceuticals Source Type: news
Beating deadly pneumonia with hormones
Researchers have identified a hormone that helps fight off a severe form of bacterial pneumonia, and that discovery may offer a simple way to help vulnerable patients. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 29, 2017 Category: Science Source Type: news
Discovery may help patients beat deadly pneumonia
(University of Virginia Health System) Researchers have identified a hormone that helps fight off a severe form of bacterial pneumonia, and that discovery may offer a simple way to help vulnerable patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 29, 2017 Category: Global & Universal Source Type: news
Why Pneumonia Often Strikes Older Adults
Former President George H.W. Bush was hospitalized on Jan. 14 following a bout of pneumonia, CNN reported Jan. 18.
In addition, Bush’s wife, former first lady Barbara Bush, was admitted to the hospital as a precaution because she was experiencing “fatigue and coughing,” according to CNN.
The 41st president turned 92 last summer, and Barbara Bush is 91. Why does pneumonia often strike older adults? [27 Devastating Infectious Diseases]
One reason is that a person’s immunity declines after age 50, “so it wouldn’t be surprising if someone who’s over 90 would have a reduced immunity,&rd...
Source: Healthy Living - The Huffington Post - January 19, 2017 Category: Consumer Health News Source Type: news
A possible treatment for severe sepsis undergoes clinical test
EU-funded project SEPCELL will conduct a clinical trial of a stem cell treatment for patients with severe sepsis caused by a severe form of community-acquired bacterial pneumonia. The trial is one of a series of steps in assessing whether the treatment is safe and efficacious for patients with this life-threatening disease. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - January 5, 2017 Category: Research Source Type: news
FDA Rejects Cempra's Pneumonia Antibiotic
The U.S. FDA has rejected Cempra ' s antibiotic, solithromycin, for treating community-acquired bacterial pneumonia (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 29, 2016 Category: Pharmaceuticals Source Type: news
FDA rejects Cempra's antibiotic for pneumonia, shares sink
(Reuters) - Cempra Inc said on Thursday the U.S. Food and Drug Administration had rejected its antibiotic for community-acquired bacterial pneumonia (CABP), citing inadequate data on the drug's impact on the liver and manufacturing issues. (Source: Reuters: Health)
Source: Reuters: Health - December 29, 2016 Category: Consumer Health News Tags: healthNews Source Type: news
FDA Advisory Committee Votes That Efficacy Results of Cempra's Solithromycin Outweigh Risks for Community-Acquired Bacterial Pneumonia
CHAPEL HILL, N.C., Nov. 04, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - November 4, 2016 Category: Drugs & Pharmacology Source Type: news
Clinton campaign releases new health information
Hillary Clinton's campaign released additional medical information Wednesday after questions about her health intensified in the wake of her pneumonia diagnosis late last week.
She was diagnosed with mild, non-contagious bacterial pneumonia, her docto... (Source: WDSU.com - Health)
Source: WDSU.com - Health - September 14, 2016 Category: Consumer Health News Source Type: news
Read The Letter Hillary Clinton's Doctor Wrote About The Presidential Nominee's Health
Hillary Clinton’s doctor penned a letter Wednesday with more information about the Democratic presidential nominee’s health.
The letter comes as Clinton recovers from a bout of pneumonia. Clinton’s physician, Dr. Lisa Bardack, said the presidential hopeful “is recovering well with antibiotics and rest.”
Below, the full text of Dr. Bardack’s letter on Clinton’s health:
This letter is a summary update on Hillary Rodham Clinton’s health since the release of my previous medical statement in July 2015.
Mrs. Clinton has been seen by me regularly this year for routine car...
Source: Healthy Living - The Huffington Post - September 14, 2016 Category: Consumer Health News Source Type: news
Medical News Today: Bacterial Pneumonia: Get the Facts
This article looks at its causes, symptoms, diagnosis, and treatment. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 26, 2016 Category: Consumer Health News Tags: Infectious Diseases / Bacteria / Viruses Source Type: news
Solithera (solithromycin) for the Treatment of Community-Acquired Bacterial Pneumonia
Solithera (solithromycin) is a next-generation macrolide antibiotic developed by Cempra as a treatment for community-acquired bacterial pneumonia. (Source: Drug Development Technology)
Source: Drug Development Technology - August 7, 2016 Category: Pharmaceuticals Source Type: news
Legionnaires' Disease Making a Comeback
Older Americans are at higher risk for the bacterial pneumonia. (Source: U.S. News - Health)
Source: U.S. News - Health - July 6, 2016 Category: Consumer Health News Authors: Lisa Esposito Source Type: news
FDA accepts Cempra's application for next-gen pneumonia treatment
Prabhavathi Fernandes, the CEO of Chapel Hill-based drug developer Cempra (Nasdaq: CEMP) will circle Dec. 27 and Dec. 28 with a big red marker on her calendar. Those are the deadlines for the U.S. Food and Drug Administration to rule on Cempra’s application for approval for a next-generation pneumonia treatment.
The FDA accepted Cempra’s applications for solithromycin, which Cempra has given the name Solithera, a treatment for treatment for community-acquired bacterial pneumonia (CABP) that… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 5, 2016 Category: Biotechnology Authors: Jason deBruyn Source Type: news
Cempra Announces FDA Acceptance of Solithera New Drug Applications in the Treatment of Community-Acquired Bacterial Pneumonia
CHAPEL HILL, N.C., July 05, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - July 5, 2016 Category: Drugs & Pharmacology Source Type: news
